Chief, Opportunistic Bacterial Pathogenesis Unit
Assistant Clinical Investigator
Specialty(s): Infectious Disease, Internal Medicine Provides direct clinical care to patients at NIH Clinical Center
Education:
M.D., 2014, Baylor College of Medicine
Biography
Dr. Abers received his B.A. summa cum laude from Northwestern University in 2010 and his M.D. with high honors from Baylor College of Medicine in 2014. As a medical student, he conducted clinical research under the mentorship of Daniel Musher. Dr. Abers completed his residency in internal medicine at Massachusetts General Hospital (MGH). As a resident, he served as a clinical teaching fellow at Harvard Medical School and conducted clinical research under the mentorship of Jatin Vyas and Michael Mansour. In 2017, Dr. Abers began his fellowship in infectious diseases at MGH and Brigham and Women’s Hospital. After completing the first year of clinical fellowship, he joined NIAID, where he began training in bench research in the Fungal Pathogenesis Section (FPS) under the mentorship of Michail Lionakis. His work at FPS focused on understanding the immune response to fungal infections. During the SARS-CoV-2 pandemic, he was a member of the NIAID COVID Consortium, where his work focused on the immunopathogenesis of COVID-19. In 2022, Dr. Abers was recruited to the NIAID Transition Program in Clinical Research. He was appointed Assistant Clinical Investigator and Chief of the Opportunistic Bacterial Pathogenesis Unit. He also serves as an attending physician on the NIH Infectious Diseases consult service.